Rare diseases
Investigational molecules
Locations
Back to France3 332 clinical trials in Corbeil Essonnes, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Pacritinib for Patients with Severe Thrombocytopenia in Myelofibrosis Conditions
FranceStudy on Birtamimab and Bortezomib for Patients with Advanced Light Chain Amyloidosis
FranceStudy on Evolocumab for Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
FranceStudy on the Effects of Povetacicept for Adults with IgA Nephropathy
FranceStudy on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema
FranceStudy on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer
FranceStudy of RO7790121 Treatment for Adults with Moderate to Severe Ulcerative Colitis: Testing Effectiveness and Safety in Initial and Long-term Therapy
FranceStudy of RO7790121 Compared to Placebo for Treatment of Adults with Moderate to Severe Ulcerative Colitis
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on novel treatments for Type 1 and Type 2 Diabetes, particularly investigating therapies like tirzepatide for glycemic control and cardiovascular outcomes in patients with obesity and diabetes.
Groundbreaking trials in Multiple Myeloma treatment, evaluating combinations of targeted therapies including elranatamab, lenalidomide, and daratumumab for newly diagnosed and relapsed cases.
Research examining innovative treatments for Immune Thrombocytopenia, Polymyalgia Rheumatica, and Lupus Nephritis, focusing on targeted therapies and steroid-sparing approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
